XML 70 R57.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restructuring Plans - Diagnostic Products segment (Details) - COVID-19 Test Manufacturing Network Restructuring Plan - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2021
Dec. 31, 2021
Restructuring Plans      
Restructuring charges     $ 441
Payments     (90)
Other non-cash     (328)
Accrued balance   $ 23 23
Inventory sold that was previously estimated to have no net realizable value   181  
Cost of products sold      
Restructuring Plans      
Restructuring charges $ 499    
Inventory-related charges      
Restructuring Plans      
Restructuring charges 248   248
Other non-cash     (248)
Fixed asset write-downs      
Restructuring Plans      
Restructuring charges 80   80
Other non-cash     (80)
Other exit costs      
Restructuring Plans      
Restructuring charges $ 171   113
Payments     (90)
Accrued balance   23 $ 23
Reduction of restructuring estimate   $ (58)